二次肿瘤细胞减灭术治疗复发性卵巢癌的研究进展  被引量:2

Research progress of the secondary cytoreductive surgery in the treatment of recurrent ovarian cancer

在线阅读下载全文

作  者:石金明 张颐[1] SHI Jinming;ZHANG Yi(Department of Gynecology,the First Hospital,China Medical University,Liaoning Shenyang 110001,China)

机构地区:[1]中国医科大学附属第一医院妇科,辽宁沈阳110001

出  处:《现代肿瘤医学》2022年第2期357-362,共6页Journal of Modern Oncology

基  金:辽宁省中央引导地方科技发展专项(编号:2019JH6/10400006);中国医科大学临床医学培育学科支持计划(妇产科学-机器人);中国医科大学国际水平项目。

摘  要:二次肿瘤细胞减灭术(secondary cytoreductive surgery,SCS)作为复发性卵巢癌的治疗方法之一,以完全切除肿瘤,使残留病灶达到最小为目标,主要适用于铂敏感性复发性上皮性卵巢癌(epithelial ovarian cancer,EOC)的治疗。这种再次手术切除肿瘤病灶的方式与传统治疗方式相比,能否改善复发性卵巢癌患者生存和预后,给患者带来新的希望,目前没有确切结论。术前准确预测SCS的效果,选择更适合进行SCS的复发性卵巢癌患者,分析影响SCS预后的因素,可以使SCS更好地应用于复发性卵巢癌的治疗。本文对SCS治疗复发性卵巢癌的适应证、手术方法以及预后影响因素进行综述。Secondary of cytoreductive surgery(SCS)is one of the treatment methods for recurrent ovarian cancer.The goal is to completely remove the tumor and minimize the residual lesions.It is mainly used for the treatment of platinum-sensitive recurrent epithelial ovarian cancer(EOC).Compared with the traditional chemotherapy method of chemotherapy,this method of resecting tumor lesions can improve the survival and prognosis of patients with recurrent ovarian cancer and bring new hope for patients with recurrent ovarian cancer.There is no definite conclusion yet.Precise prediction of the effects of SCS,selection of patients more suitable for SCS,and analysis of factors affecting the prognosis of SCS patients will greatly improve the survival of SCS patients and make SCS better applied to the treatment of recurrent ovarian cancer.This article reviews the safety and feasibility of SCS,surgical methods,and factors affecting the prognosis of SCS.

关 键 词:二次肿瘤细胞减灭术 复发性卵巢癌 安全性和可行性 预后 肿瘤细胞减灭术 

分 类 号:R737.31[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象